|February 22, 2012|
|09:46 EDT||WIRE, GRMN, CLH, TXRH, FIRE, CHS, MDCO, CYH, AUBN||Gappers report: Bullish gaps|
This is a list of stocks making unusual moves on the open versus the prior day close. Gapping stocks often have excessive movements during the day and in the days thereafter. We use 5% for filter criteria and scanned for stocks that traded above $10 the prior day. GAPPING UP: WIRE 5.13%, CLH 5.26%, AUBN 5.57%, MDCO 8.11%, TXRH 9.26%, GRMN 9.71%, CYH 11.67%, CHS 13.35%, FIRE 17.09%.
News For AUBN;CHS;CLH;CYH;FIRE;GRMN;MDCO;TXRH;WIRE From The Last 14 Days
|November 24, 2015|
|07:30 EDT||CHS||Chico's approves $300M share repurchase program|
Subscribe for More Information
|November 23, 2015|
|14:07 EDT||CHS||Chico's volatility elevated into Q3 and outlook |
Subscribe for More Information
|10:00 EDT||CHS||On The Fly: Analyst Downgrade Summary|
Today's noteworthy downgrades include: Aixtron (AIXG) downgraded to Neutral from Overweight at JPMorgan... Cavium (CAVM) downgraded on checks at JMP Securities... Chico's (CHS) downgraded to Underperform from Peer Perform at Wolfe Research... Chipotle (CMG) downgraded on new E coli infections at Sterne Agee CRT... Constant Contact (CTCT) downgraded to Sell from Hold at Stifel... Fairchild (FCS) downgraded to Neutral from Positive at Susquehanna... Haemonetics (HAE) downgraded to Underperform from Market Perform at Raymond James... Jumei (JMEI) downgraded to Underperform from Buy at CLSA... Phillips 66 (PSX) downgraded to Sell from Neutral at Goldman... Power Integrations (POWI) downgraded to Neutral from Buy at Sidoti... Tata Motors (TTM) downgraded to Sell from Neutral at Goldman... Textura (TXTR) downgraded to Neutral from Outperform at Credit Suisse... TriVascular (TRIV) downgraded to Neutral from Buy at BTIG... Viacom (VIAB) downgraded to Hold from Buy at Deutsche Bank.
|09:31 EDT||CHS||Chico's downgraded to Underperform from Peer Perform at Wolfe Research|
Subscribe for More Information
|November 20, 2015|
|16:35 EDT||CYH||Stocks follow worst week of year with one of best after Fed minutes give clarity|
Stocks ended the week with sharp gains, with the S&P rising over 3%, bouncing back from last week's equally sharp declines. The primary driver of the move appeared to be the Fed minutes, which provided further clarity that December's meeting is firmly on the table for the central bank to make its first rate hike in many years. MACRO NEWS: In the U.S., the minutes from the Fed's last FOMC meeting showed that most participants expect that rate hike conditions will be met by their December meeting. The Fed repeated its constant refrain, though, that the actual decision would depend on the implications for the medium-term outlook from recent economic data... The consumer price index rose 0.2% in October, as expected. When food and energy prices are stripped out, the "core" CPI also rose 0.2%, also matching the consensus forecast. Industrial production slid 0.2% in October, versus expectations for it to have risen 0.1%. Capacity utilization came in as expected at 77.5%. Housing starts fell 11.0% to a 1.06M pace in October, weaker than the expected rate of 1.16M. Building permits, however, rose 4.1% to a 1.15M rate, versus an expected rise of 3.8%. The Empire State index, which measures manufacturing in the N.Y. region, edged up to -10.74 in November, up from last month's -11.4, but below expectations for a -6.5 reading... In Europe, minutes from the most recent European Central Bank policy meeting showed that some participants called for more stimulus amid deflation risks, weak oil prices and a sluggish recovery in the regions' economy... In Asia, Japan's gross domestic product declined 0.8% in the third quarter, missing expectations for a 0.2% decrease and taking the nation's economy back into recession. Later in the week, the Bank of Japan maintained its current pace of monetary stimulus, as expected. Meanwhile, China's Securities Regulatory Commission has restarted initial public offerings for five companies to list on the Shanghai stock exchange and five in Shenzhen, ending a five-month freeze on IPOs. COMPANY NEWS: Shares of Wal-Mart advanced 3.5% on Tuesday after the world's largest retailer reported better than expected quarterly earnings and gave a fiscal year profit outlook that was higher than expected at the midpoint of the company's range. Another retail giant and fellow Dow member, Home Depot (HD), gained more than 4% that day after its own better than expected quarterly reports, which came on the heels of largely disappointing reports from other major retailers. Target (TGT), however, fell more than 4% on Wednesday after the retailer reported in-line quarterly sales and profits and narrowed the range of its fiscal year earnings view. Among others reporting earnings this week, TJX Companies (TJX) and Keurig Green Mountain (GMCR) rose immediately following their reports, while Kirkland's (KIRK) and Nimble Storage (NMBL) fell right after their own... The biggest U.S. health insurer said Thursday that it is considering pulling out of Obamacare due to losses it has suffered from its participation in the program and cut its profit outlook for this fiscal year, sending its shares and those of its industry peers lower. UnitedHealth (UNH) fell after trimming its fiscal 2015 earnings outlook, citing the Affordable Care Act, and stating that it is "evaluating the viability of the insurance exchange product segment." Aetna (AET), Humana (HUM), Anthem (ANTM) and Cigna (CI) all declined following their rival's announcement, though Aetna and Anthem followed the news up Friday morning by each reaffirming their fiscal 2015 earnings outlooks. Hospital stocks fell as well, with HCA Holdings (HCA), LifePoint (LPNT), Community Health (CYH) and Tenet (THC) all ending the Thursday lower by 6% or more... Square (SQ) rose 45% to close its first day as a publicly-traded company at $13.07 after pricing its initial public offering at $9 per share. Twitter (TWTR), which, like Square, claims Jack Dorsey as its CEO, advanced a bit following Square's public debut as well. Another high-profile tech company also gained in its first day of public trading, as Match Group (MTCH), the owner of dating app Tinder and other online dating services, climbed 22.8% to $14.74 after pricing its IPO at $12 per share... Bloomberg reported that Pfizer (PFE) is nearing an agreement to acquire Allergan (AGN) for $370 to $380 per share, citing people familiar with the matter. CNBC's David Faber then reported that deal talks are in the "final innings" and centered on an all stock transaction whereby Pfizer would offer 11-plus shares per Allergan share. Then, people close to the talks told Financial Times that the U.S. drugmaker is preparing to offer more than $380 per share for Allergan. Amid all these reports, Treasury Secretary Jacob Lew said that his department will release "targeted guidance" later this week meant to "deter and reduce further the economic benefits of corporate inversions" like the one being contemplated by the drugmakers. In other M&A news, Starwood Hotels & Resorts (HOT) found a buyer, but not the one that media reports had been foreshadowing. Starwood and Marriott (MAR) announced a deal under which the companies will combine in a cash and stock transaction valued at $12.2B to create the world's largest hotel company. Canadian Pacific (CP) and Norfolk Southern (NSC) both advanced after Canadian submitted a bid to acquire Norfolk, though the latter immediately criticized the offer as "low-premium." Airgas (ARG) surged about 30% after agreeing to be acquired by France's Air Liquide for $143 per share. Fairchild (FCS) jumped 8.5% after agreeing to be acquired for $20 per share by ON Semiconductor (ON)... Qualcomm (QCOM) dropped sharply after disclosing that Korea's Fair Trade Commission alleged the company does not "properly negotiate" aspects of its licenses and may be violating Korean competition law... SunEdison (SUNE) had another tough week, falling about 43% amid ongoing concerns regarding its liquidity and after quarterly filings revealed that several prominent hedge funds exited or trimmed their stakes in the company... ConAgra (CAG) gained 4% on Wednesday after announcing plans to separate into two independent public companies... Nike (NKE) advanced to close out the week after the footwear and sports apparel giant announced a two-for-one stock split, a $12B stock repurchase program and plans to boost its dividend... Chipotle Mexican Grill (CMG) dropped sharply after the Center for Disease Control announced that three additional states have reported people infected within the E. coli outbreak linked to the company's restaurants. INDEXES: The Dow gained about 3.35% to close at 17,823.81, the S&P 500 rose about 3.27% to close at 2,089.17, and the Nasdaq advanced about 3.58% to close at 5,104.92.
|12:02 EDT||MDCO||The Medicines Co. receives EC approval for IONSYS |
The Medicines Company announced that the European Commission has granted marketing authorization for IONSYS(40 micrograms per dose transdermal system), with active ingredient fentanyl, for the management of acute moderate-to-severe, post-operative pain in adult patients for use in the hospital. IONSYS will be the only needle-free, patient-controlled, pre-programmed iontophoretic transdermal delivery system for use in adult patients requiring opioid analgesia in EU hospital settings. The marketing authorization follows the issuance of a positive opinion in September by the Committee for Medicinal Products for Human Use of the European Medicines Agency and is now valid in the 31 countries of the European Economic Area, which includes all 28 European Union Member States, plus Norway, Iceland and Liechtenstein. A supplemental new drug application for IONSYS was approved by the U.S. FDA in April 2015 with an approved IONSYS Risk Evaluation Mitigation Strategy program. The product is commercially available in the U.S. as of July 2015.
|November 19, 2015|
|16:23 EDT||CYH||On The Fly: Top stock stories for Thursday|
The major averages spent most of the day in a narrow range bouncing around the flatline, seeming content to consolidate the gains from their rally of the last three days. The market internals confirmed the lackluster session, as the number of advancing stocks were generally in line with declining stocks. Oil prices remained under pressure for much of the session, but closed the day little changed, similar to equities. ECONOMIC EVENTS: In the U.S., jobless claims are still near four-decade lows, with 271,000 first-time claims filed in the week ended November 14. The Philly Fed index rose 6.4 points to 1.9 in November, better than the forecast for a -0.5 reading. In Europe, minutes from the most recent European Central Bank policy meeting showed that some participants called for more stimulus amid deflation risks, weak oil prices and a sluggish recovery in the regions' economy. In Asia, the Bank of Japan maintained its current pace of monetary stimulus, as expected. COMPANY NEWS: The biggest U.S. health insurer said this morning that it is considering pulling out of Obamacare due to losses it has suffered from its participation in the program and cut its profit outlook for this fiscal year, sending its shares and those of its industry peers lower. UnitedHealth (UNH) fell $6.62, or 5.65%, to $110.63 after trimming its fiscal 2015 earnings outlook, citing the Affordable Care Act, and stating that it is "evaluating the viability of the insurance exchange product segment." Meanwhile, Aetna (AET) declined 6.5%, Humana (HUM) dropped 4%, Anthem (ANTM) declined almost 7% and Cigna (CI) slid over 5% following their rival's announcement. Hospital stocks fell as well, with HCA Holdings (HCA), LifePoint (LPNT), Community Health (CYH) and Tenet (THC) all ending the day lower by 6% or more... Last night, Bloomberg reported that Pfizer (PFE) is nearing an agreement to acquire Allergan (AGN) for $370 to $380 per share, citing people familiar with the matter. CNBC's David Faber then reported that deal talks are in the "final innings" and centered on an all stock transaction whereby Pfizer would offer 11-plus shares per Allergan share. Then, people close to the talks told Financial Times that the U.S. drugmaker is preparing to offer more than $380 per share for Allergan. Amid all these reports, Treasury Secretary Jacob Lew said that his department will release "targeted guidance" later this week meant to "deter and reduce further the economic benefits of corporate inversions" like the one being contemplated by the drugmakers. Government intervention concerns appeared to trump the pricing reports, as Allergan closed the day 2.8% lower at $301.73, while Pfizer fell 3% to $32.29 per share... Intel (INTC) rose 3.4% to $34.30 after the chipmaking giant hosted its annual investor meeting, at which it announced an increase to its dividend and guided for "mid-single digits" percentage revenue growth in fiscal 2016. MAJOR MOVERS: Among the notable gainers was Keurig Green Mountain (GMCR), which surged $7.38, or 18.22%, to $47.88 after it reported better than expected quarterly earnings and guided for fiscal 2016. Also higher was Square (SQ), which rose $4.07, or 45%, to close its first day as a publicly-traded company at $13.07 after pricing its initial public offering at $9 per share. Twitter (TWTR), which, like Square, claims Jack Dorsey as its CEO, gained 1.6% to $26.32 following Square's public debut. Another high-profile tech company also gained in its first day of public trading, as Match Group (MTCH), the owner of dating app Tinder and other online dating services, climbed 22.8% to $14.74 after pricing its IPO at $12 per share. Among the noteworthy losers was Kirkland's (KIRK), which fell nearly 33% to $13.60 after the company reported downbeat quarterly earnings and provided lower than expected guidance. Also lower were shares of AMAG Pharmaceuticals (AMAG), which lost 9.84% to $26.20 after it received a complete response letter from the FDA for its proposed treatment to reduce the risk of preterm birth in at-risk patients. INDEXES: The Dow fell 4.41, or 0.02%, to 17,732.75, the Nasdaq slid 1.56, or 0.03%, to 5,073.64, and the S&P 500 declined 2.34, or 0.11%, to 2,081.24.
|07:16 EDT||GRMN||Garmin to appeal ITC judgment in Johnson Outdoors investigation|
Garmin International Inc., a unit of Garmin Ltd. (GRMN), announced that the International Trade Commission issued a final determination in the investigation brought by Johnson Outdoors (JOUT) against Garmin. The ITC concluded that first generation Garmin SideVu scanning sonar products were too similar to some claims of one of the three patents asserted by Johnson Outdoors. The ITC ordered that these Garmin products be excluded from import into the United States; however, the ITC is allowing Garmin to freely import these products temporarily and further recommended that Garmin be allowed to freely import modified products permanently. The ITC found that Garmin did not infringe Johnson Outdoors' two other patents. "Garmin disagrees with the ITC and plans to appeal the determination," said Andrew Etkind, Garmin vice president and general counsel. "Nevertheless, we do not expect the ruling to have any impact on Garmin customers or products. Garmin has already modified our software to address the ITC's ruling, and we are ready to ship those products today. The ruling will have no impact on Garmin products already purchased by our customers and dealers, or any products purchased going forward."
|05:15 EDT||GRMN||Johnson Outdoors, Hummingbird receive favorable ITC ruling against Garmin |
Johnson Outdoors (JOUT) confirmed that the full International Trade Commission, or ITC, has affirmed the initial determination by the Administrative Law Judge that Garmin (GRMN) violated section 337 of the Tariff Act of 1930 by importing and selling SideVu sonars, which the ITC affirmed infringe a Johnson Outdoors Inc. side scan sonar patent used in certain Humminbird fishfinders. The ITC affirmed that: All three patents asserted by Johnson Outdoors are valid and enforceable Numerous models of Garmin's SideVu sonars directly infringe six Johnson Outdoors patent claims. The ITC also issued: A limited exclusion order barring Garmin's infringing SideVu sonar systems and components thereof which are manufactured overseas from import into the United States; A cease and desist order prohibiting Garmin from selling or distributing any infringing product or component thereof from its inventory. The orders will go into effect pending the mandatory review by the U.S. trade representative.
|November 18, 2015|
|15:49 EDT||GRMN||FCC documents point to new Garmin 'smart TV' streaming device|
Subscribe for More Information
|07:05 EDT||GRMN||Garmin announces GAD 27 integrated controller|
Subscribe for More Information
|November 17, 2015|
|09:02 EDT||GRMN||Analyst pans competing products, says buy Fitbit|
Shares of previous high-flier Fitbit (FIT) have dropped about 30% in the last two weeks following the company's third quarter earnings report, but an analyst at Bank of America upgraded his view of the fitness tracker maker this morning, saying that now is the time to buy ahead of fourth quarter results that may be boosted by the "underwhelming" new products being launched by its competitors. UNDERWHELMING COMPETITION: Fitbit's sales guidance for this holiday quarter looks conservative, contends Bank of America analyst Nat Schindler, who notes that the company only had the launch of one new product last December but will have the Charge, Charge HR and Surge to drive sales this season. Schindler also notes that the company's international advertising has expanded into more countries ahead of the holidays this year. Key, however, may be the "underwhelming" lineup of new or updated fitness trackers launched by competitors, such as the Microsoft's (MSFT) Band 2, Jawbone's UP4 and Sony's (SNE) Smartband 2, many of which have only minor improvements and no "must have" features to pull consumers away from Fitbit, Schindler told investors in his research note. PLATFORM PICKING UP STEAM: The analyst also pointed out that Fitbit now has more than 20 companies signed onto its health and wellness platform, including big names like Target (TGT) and Barclays (BCS), which he believes should help drive revenue beats in the upcoming fiscal year due to increased device sales. Also, the additional dashboard data should help Fitbit maintain long-term user engagement, said Schindler. APPLE WATCH: Apple's (AAPL) Apple Watch is largely viewed as the biggest potential competitive threat to Fitbit's offerings, but on the fitness tracker maker's last earnings call CEO James Park said Fitbit's products differ from those of its competitors in several key aspects, including pricing, cross-platform compatibility, brand awareness and product line breadth. Other wearables makers include Garmin (GRMN) and Samsung. PRICE ACTION: Since the day after Fitbit's last earnings report after the market close on November 2, its shares have fallen about 29.5% to close yesterday at $28.80. In pre-market trading this morning, Fitbit shares rose 2% to $29.40.
|November 16, 2015|
|16:43 EDT||GRMN||Greenlight Capital added Apple, sold some SunEdison |
Greenlight Capital gave a quarterly update on its stakes in a filing this afternoon. NEW STAKES: CNX Coal Resources (CNXC), Garmin (GRMN), Terraform Global (GLBL), and Liberty Global (LILA). INCREASED STAKES: Apple (AAPL), Michael Kors (KORS), Dillard's (DDS), UIL Holdings (UIL), and Twenty-First Century Fox (FOXA). DECREASED STAKES: SunEdison (SUNE), Micron (MU), Voya (VOYA), Applied Materials (AMAT), and SunEdison Semiconductor (SEMI). LIQUIDATED STAKES: Citizens Financial (CFG), Lam Research (LRCX), Spirit AeroSystems (SPR), Hertz (HTZ), and Macy's (M).
|10:02 EDT||TXRH||Texas Roadhouse added to Best Ideas List at Longbow|
Subscribe for More Information
|07:04 EDT||GRMN||Garmin introduces GPS 73 marine handheld|
Garmin International Inc., a unit of Garmin Ltd., announced the GPS 73, a new low-cost marine handheld designed for mariners who want a simple, rugged, and reliable navigation solution. This easy-to-use handheld is packed with marine-specific features like man overboard, marine alarms, routing planning, and navigation. New SailAssist has also been added, offering sailing-inspired features like virtual starting line, race countdown times, distance to start line, speed history graph, and tack assist.
|07:03 EDT||GRMN||Garmin says GSX 70 selected by Northrop Grumman for RQ-4 UAS|
Garmin International, a unit of Garmin Ltd. (GRMN), announced the selection of the GSX 70, a full-featured solid-state weather radar by Northrop Grumman (NOC) for the U.S. Air Force fleet of RQ-4 Global Hawk unmanned aircraft systems. Equipped to fly at a maximum altitude of 60,000 feet with an endurance of 32+ hours, the Global Hawk is a high-altitude, long-endurance UAS.
|November 13, 2015|
|15:04 EDT||GRMN||Leerink digital health analyst holds analyst/industry conference call|
Digital Health Analyst Wardell discusses Fitbit and how many units will it sell in Q4, the Apple Watch and whether it is in a different product category than Fitbit on an Analyst/Industry conference call to be held on November 17 at 12:30 pm.
|14:52 EDT||MDCO||Federal Circuit overturns District Court decision on Angiomax patents|
Subscribe for More Information
|13:57 EDT||MDCO||Appeals court vacates decision invalidating Medicines Co. Angiomax patents|
Subscribe for More Information
|13:38 EDT||MDCO||The Medicines Co. jumps 9% following reports of court decision|
Shares of The Medicines Co. jumped after reports surfaced that an appeals court vacated the decision invalidating Angiomax patents.